COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,935 Articles (22,057 medRxiv, 7,878 bioRxiv)

Most recent first Previous |  Page 317: Articles 3161-3170  | Next

The Breadth of the Neutralizing Antibody Response to Original SARS-CoV-2 Infection is Linked to the Presence of Long COVID Symptoms
Buck, A. M., Deitchamn, A. N., Takahashi, S., Lu, S., Goldberg, S. A., Hoh, R., Williams, M. C., Kerbleski, M., Deveau, T.-M., Munter, S. E., Lombardo, J., Wrin, T., Petropoulos, C. J., Durstenfeld, M. S., Hsue, P. Y., Kelly, J. D., Greenhouse, B., Martin, J. N., Deeks, S. G., Peluso, M. J., Henrich, T. J.
10.1101/2023.03.30.23287923 — Posted: 2023-03-31
miRNA binding pressure channels evolution of SARS-CoV-2 genomes
Zhiyanov, A., Shkurnikov, M., Nersisyan, A., Cai, H., Baranova, A., Tonevitsky, A.
10.1101/2023.03.31.535057 — Posted: 2023-03-31
Determinants of species-specific utilization of ACE2 by human and animal coronaviruses
Wang, Q., Noettger, S., Xie, Q., Pastorio, C., Seidel, A., Mueller, J. A., Jung, C., Jacob, T., Sparrer, K. M. J., Zech, F., Kirchhoff, F.
10.1101/2023.03.31.535059 — Posted: 2023-03-31
S:D614G and S:H655Y are gateway mutations that act epistatically to promote SARS-CoV-2 variant fitness
Yurkovetskiy, L., Egri, S., Kurhade, C., Diaz-Salinas, M. A., Jaimes, J. A., Nyalile, T., Xie, X., Choudhary, M. C., Dauphin, A., Li, J. Z., Munro, J. B., Shi, P.-Y., Shen, K., Luban, J.
10.1101/2023.03.30.535005 — Posted: 2023-03-31
Explicit Modelling of Antibody Levels for Infectious Disease Simulations in the Context of SARS-CoV-2
Mueller, S. A., Paltra, S., Rehmann, J., Nagel, K., Conrad, T. O. F.
10.1101/2023.03.31.535072 — Posted: 2023-03-31
Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epithelia
Castaneda, D. C., Jangra, S., Yurieva, M., Martinek, J., Callender, M., Coxe, M., Choi, A., Diego, J. G.-B., Lin, J., Wu, T.-C., Marches, F., Chaussabel, D., Yu, P., Salner, A., Aucello, G., Koff, J., Hudson, B., Church, S. E., Gorman, K., Anguiano, E., Garcia-Sastre, A., Williams, A., Schotsaert, M., Palucka, K.
10.1101/2023.03.30.534980 — Posted: 2023-03-31
Post-infection treatment with the E protein inhibitor BIT225 reduces disease severity and increases survival of k18-hACE2 transgenic mice infected with a lethal dose of SARS-CoV-2
Ewart, G., Bobardt, M., Bentzen, B. H., Yan, Y., Thomson, A., Klumpp, K., Becker, S., Rosenkilde, M., Miller, M., Gallay, P.
10.1101/2023.03.29.534854 — Posted: 2023-03-30
Broad and potent neutralizing mAbs are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection
Seow, J., Shalim, Z. A., Graham, C., Kimuda, S., Pillai, A., Lechmere, T., Kurshan, A., Khimji, A., Snell, L., Nebbia, G., Mant, C., Waters, A., Fox, J., Malim, M. H., Doores, K. J.
10.1101/2023.03.30.534872 — Posted: 2023-03-30
NETosis Induced by Serum of Patients with COVID-19 is Reduced with Reparixin or Antibodies Against DEK and IL-8
Kilic, I. B., Yasar, A., Yalim Camci, I., Guzel, T., Karahasan, A., Yagci, T., Cine, N., Kandilci, A.
10.1101/2023.03.30.534873 — Posted: 2023-03-30
Improving mRNA vaccine safety and efficiency with cationized lipid nanoparticle formula
Peng, X., Liao, G., Ren, D., Zhou, Y., Wu, X., Lei, Y., Zhang, Y., Chen, L., He, C., Zhang, Y., Yin, H., Yang, G., Xu, K.
10.1101/2023.03.29.534838 — Posted: 2023-03-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).